The primary method for measuring brain metabolism in humans is positron emission
tomography (PET) imaging using the tracer 18F-fluorodeoxyglucose (FDG). Standardized …

This study sought to identify a reference tissue‐based quantification approach for improving
the statistical power in detecting changes in brain glucose metabolism, amyloid, and tau …

Purpose The aim of this study was to investigate the effects of atrophy correction on the
results of 18 F-fluorodeoxyglucose positron emission tomography (FDG PET) in the context …

In the recently revised diagnostic criteria for Alzheimer disease (AD), the National Institute
on Aging and Alzheimer Association suggested that confidence in diagnosing dementia due …

PET with the glucose analog FDG as a tracer is a mature and increasingly available clinical
imaging technique that can improve the diagnostic accuracy for Alzheimer's disease, which …

Abstract [18 F]-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) is a widely
used diagnostic tool that can detect and quantify pathophysiology, as assessed through …

An emerging issue in neuroimaging is to assess the diagnostic reliability of PET and its
application in clinical practice. We aimed at assessing the accuracy of brain FDG-PET in …

A cross-sectional group study of the effects of aging on brain metabolism as measured with
18 F-FDG-PET was performed using several different partial volume correction (PVC) …

Abstract Purpose Although 18 F-fluorodeoxyglucose (FDG) PET is an established imaging
technique to assess brain glucose utilisation, accurate measurement of tracer concentration …

Abstract 18 F–fluoro-deoxy-glucose Positron Emission Tomography (FDG-PET) allows early
identification of neurodegeneration in dementia. The use of an optimized method based on …